Kernicterus

CDC funds infant brain damage prevention initiatives

Published in Medical Letter on the CDC and FDA, March 9th, 2003

The U.S. Centers for Disease Control and Prevention (CDC) is providing approximately $1.3 million in funding over the next 3 years for research and the prevention of kernicterus, a serious but preventable type of brain damage in infants that can lead to cerebral palsy, hearing loss, and complications with vision and teeth.

Recipients are the Pennsylvania Hospital in collaboration with Parents of Infants and Children with Kernicterus (PICK) and Saint Peter's University Hospital, UMDNJ-Robert Wood Johnson Medical School.

Kernicterus is caused by severe and untreated jaundice. While jaundice is very common in newborn infants, any baby with severe...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2003-03-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry